These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8485566)

  • 1. Ophthalmologic safety profile of antimalarial drugs.
    Rynes RI; Bernstein HN
    Lupus; 1993 Feb; 2 Suppl 1():S17-9. PubMed ID: 8485566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI
    Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Hydroxy)-chloroquine retinal toxicity: two case reports and safety guidelines.
    Herman K; Leys A; Spileers W
    Bull Soc Belge Ophtalmol; 2002; (284):21-9. PubMed ID: 12161987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal pigment epithelium--the point about safety of antimalarial agents].
    Vanheesbeke A
    Bull Soc Belge Ophtalmol; 2007; (304):47-58. PubMed ID: 17718227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular toxicity of hydroxychloroquine.
    Yam JC; Kwok AK
    Hong Kong Med J; 2006 Aug; 12(4):294-304. PubMed ID: 16912357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ophthalmological monitoring protocol for patients treated with long-term antimalarials or vigabatrin].
    Ingster-Moati I; Orssaud C
    J Fr Ophtalmol; 2009 Jan; 32(1):83-8. PubMed ID: 19515321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of color vision defects in chloroquine retinopathy.
    Vu BL; Easterbrook M; Hovis JK
    Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A
    Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular safety of hydroxychloroquine.
    Bernstein HN
    Ann Ophthalmol; 1991 Aug; 23(8):292-6. PubMed ID: 1952638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A; West B
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects of some modern drugs on the visual apparatus].
    Knobloch R
    Cesk Oftalmol; 1971 Nov; 27(6):367-73. PubMed ID: 5138253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blue-yellow perimetry can be an early detector of hydroxychloroquine and chloroquine retinopathy.
    Razeghinejad MR; Torkaman F; Amini H
    Med Hypotheses; 2005; 65(3):629-30. PubMed ID: 15949899
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity of antimalarial drugs in rheumatoid arthritis.
    Rynes RI
    Agents Actions Suppl; 1993; 44():151-7. PubMed ID: 8372725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    ; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
    Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial drugs, pregnancy and lactation.
    Parke AL
    Lupus; 1993 Feb; 2 Suppl 1():S21-3. PubMed ID: 8485567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of antimalarial drugs in rheumatic diseases.
    Jover JA; Leon L; Pato E; Loza E; Rosales Z; Matias MA; Mendez-Fernandez R; Díaz-Valle D; Benitez-Del-Castillo JM; Abasolo L
    Clin Exp Rheumatol; 2012; 30(3):380-7. PubMed ID: 22339928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.